Albemarle Corporation (NYSE:ALB - Get Free Report) shares gapped down prior to trading on Tuesday . The stock had previously closed at $80.76, but opened at $78.24. Albemarle shares last traded at $79.21, with a volume of 1,052,822 shares.
Wall Street Analyst Weigh In
Several research firms have recently commented on ALB. Deutsche Bank Aktiengesellschaft set a $74.00 price target on Albemarle and gave the stock a "hold" rating in a report on Monday, August 4th. KeyCorp reiterated a "sector weight" rating on shares of Albemarle in a report on Wednesday, July 30th. Citigroup cut their price target on shares of Albemarle from $85.00 to $64.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Mizuho set a $76.00 price target on shares of Albemarle in a research report on Tuesday, July 15th. Finally, TD Securities lowered their price objective on Albemarle from $115.00 to $65.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $88.06.
Get Our Latest Analysis on Albemarle
Albemarle Stock Down 1.6%
The company has a debt-to-equity ratio of 0.38, a current ratio of 2.31 and a quick ratio of 1.47. The business has a 50 day simple moving average of $67.76 and a 200 day simple moving average of $67.99. The company has a market capitalization of $9.35 billion, a price-to-earnings ratio of -8.53 and a beta of 1.63.
Albemarle (NYSE:ALB - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.94. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%. The company had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.23 billion. During the same period in the prior year, the firm earned $0.04 earnings per share. The firm's revenue was down 7.0% compared to the same quarter last year. As a group, equities analysts predict that Albemarle Corporation will post -0.04 earnings per share for the current fiscal year.
Albemarle Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, September 12th will be paid a $0.405 dividend. This represents a $1.62 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Friday, September 12th. Albemarle's dividend payout ratio (DPR) is presently -17.38%.
Institutional Trading of Albemarle
Hedge funds have recently modified their holdings of the stock. Hantz Financial Services Inc. raised its stake in shares of Albemarle by 10,050.0% in the second quarter. Hantz Financial Services Inc. now owns 406 shares of the specialty chemicals company's stock valued at $25,000 after acquiring an additional 402 shares in the last quarter. Orion Capital Management LLC purchased a new stake in Albemarle during the 4th quarter worth about $35,000. SJS Investment Consulting Inc. acquired a new position in shares of Albemarle during the 1st quarter worth about $32,000. National Pension Service increased its holdings in shares of Albemarle by 74.5% in the 1st quarter. National Pension Service now owns 452 shares of the specialty chemicals company's stock valued at $33,000 after acquiring an additional 193 shares during the last quarter. Finally, Costello Asset Management INC acquired a new stake in shares of Albemarle during the 1st quarter worth about $36,000. 92.87% of the stock is currently owned by institutional investors and hedge funds.
Albemarle Company Profile
(
Get Free Report)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.